Most automakers’ Q2 sales in the U.S. didn’t fare well, and of the three that did experience gains, one stood out ...

Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Abbott, a global healthcare leader, has reported strong results for its second quarter of 2025. According to the company's ...

Elon Musk's dream of having a top-selling electric pickup may be a thing of the past as the Cybertruck continues to see ...

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

The Motley Fool. DATE Thursday, July 17, 2025 at 9 a.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer — Robert ...

Abbott (NYSE: ABT) shares dipped before hours today on second-quarter results that came in ahead of the consensus forecast.

General Motors' Hummer EV and Ford's F-150 Lightning beat Tesla's Cybertruck in the US electric pick-up market for Q2 2025.

A total of 310,839 new electric cars were sold in the US in the second quarter, according to data from Kelley Blue Book.

Morgan Stanley’s second-quarter profit rose, buoyed by a surge in its trading business during tariff-related market turmoil.

The GMC Hummer EV outperformed Tesla's Cybertruck in the second quarter of 2025, with sales figures revealing a significant drop in Cybertruck purchases.